Can this be signed electronically?

Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure intent, consent, attribution, and retention are documented for enforceability.

Is eSubmission HIPAA-compliant?

It can be if the vendor signs a Business Associate Agreement and implements safeguards (access controls, encryption, audit trail). HIPAA requires administrative, physical, and technical protections for PHI.

What if a specimen was mislabeled?

Document the chain-of-custody discrepancy, notify the lab and treating clinician, and repeat collection if clinically required; chain-of-custody problems can invalidate results for employment or legal purposes.

Who is authorized to sign the evaluation?

The treating clinician or designated medical reviewer with appropriate credentials should sign; the signature must include name, credentials, license number, and date to be admissible and actionable.

How do I correct an error after signing?

Add a signed addendum noting the correction and reason; do not alter the original signed record. Maintain both original and addendum with an audit trail for transparency.

How long must the evaluation be kept?

Follow HIPAA baseline retention of six years from creation or last effective date (45 CFR §164.530(j)), and extend retention per any applicable state or program-specific requirement.

Electronic Signature
Templates
Healthcare
Healthcare Substance Evaluation

Healthcare Substance Evaluation

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE SUBSTANCE EVALUATION

This Substance Evaluation documents the patient's reported substance use, medical and psychosocial history, screening results, clinical impressions, and recommended treatment options. Information provided will be used for clinical assessment, treatment planning, and, with authorization, coordination of care. Limits of confidentiality include: disclosure required by law for suspected abuse or neglect, imminent risk of harm to self or others, and disclosures compelled by court order.

Patient Information

Patient Full Name

Date of Birth:

Gender:

Phone:

Address Emergency Contact (Name and Relationship)

Emergency Contact Phone:

Relationship to Patient (if signing):

Insurance / Payer Information

Primary Insurance Provider

Policy/ID #:

Group #:

Subscriber Name:

Referral & Presenting Problems

Referred By Primary Reason for Evaluation

Substance Use History

Check all substances used in the past and provide frequency/route/recency information where applicable.

Substances (check all that apply)

Alcohol Cannabis Opioids (prescription/heroin) Cocaine/Crack Methamphetamine Benzodiazepines Other Stimulants Inhalants Other

Age at first use:

Last use (substance-specific):

Typical amount/route:

Use pattern (past 30 days) History of overdose

Yes No

Screening Instruments / Behavioral Items

Complete screening items; enter scores where applicable. Clinician may administer validated instruments and record results below.

CAGE-AID Items (check if present)

Felt the need to cut down on use
People annoyed by use
Felt guilty about use
Morning use to steady nerves or get going

Screening Score (CAGE-AID or other):

Medical & Mental Health History

Current Medications Allergies Chronic Medical Conditions Psychiatric History / Diagnoses

Prior psychiatric hospitalization

Yes No

Social, Legal, and Functional Status

Employment Status Housing Stability Legal Issues

Prior Treatment for Substance Use

Previous Treatment Episodes

Risk Assessment

Assess current risks including suicidal ideation, homicidal ideation, violent behavior, and acute intoxication.

Suicidal Ideation Yes No

Homicidal Ideation / Violent Behavior Yes No

Risk Assessment Details

Clinical Impression & Recommendations

Clinical Impression / Working Diagnosis Recommended Level of Care Recommended Interventions / Treatment Plan Recovery Supports / Referrals

Suggested Follow-up Date:

Urgency Level:

Consent, Authorization & Confidentiality

By signing below the patient (or authorized representative) certifies that the information provided is true and complete to the best of their knowledge. The patient authorizes the clinician to obtain or release health information as necessary to coordinate care, subject to written authorization where required. This authorization is voluntary and may be revoked in writing, except to the extent that action has already been taken in reliance upon it. This authorization expires on the date specified below or upon earlier written revocation.

Authorization Expiration Date

Clinician / Evaluator Section

Clinician Name and Credentials Evaluation Date Clinician Comments

Patient Name:

By:

Date:

What the Healthcare Substance Evaluation Is and when it’s used

A Healthcare Substance Evaluation documents a clinical assessment of a patient’s exposure to, use of, or reaction to one or more chemical or controlled substances. It typically combines patient history, observed signs and symptoms, laboratory or toxicology results, and the clinician’s interpretation. The document supports diagnosis, treatment decisions, workplace fitness determinations, benefit or disability reviews, and any required reporting while remaining subject to medical record privacy obligations such as HIPAA.

Why a clear, complete evaluation matters

A complete Healthcare Substance Evaluation provides an auditable clinical record for treatment, legal, occupational, and billing purposes, reduces follow-up questions, and helps ensure appropriate care while meeting privacy and evidentiary standards under HIPAA and applicable state law.

Who prepares and relies on these evaluations

Clinical teams and administrative stakeholders use this document to record findings, coordinate care, and support downstream decisions.

Primary care and emergency clinicians who diagnose, treat, and document substance-related conditions.
Occupational health and employer medical reviewers evaluating fitness for duty or workplace exposure.
Insurers, case managers, and disability reviewers who need clinical evidence for coverage determinations.

Accurate completion reduces legal and administrative friction and ensures records are fit for clinical, payer, and regulatory uses.

Step-by-step: completing a Healthcare Substance Evaluation

Follow this sequence to create a compliant, clinically useful record.

01

Verify identity: Confirm patient identity using MRN and DOB before documenting.
02

Record history: Capture substance use, exposure context, and relevant medical history.
03

Order or attach tests: Include specimen ID and lab results or attach final reports.
04

Sign and timestamp: Clinician signs, dates, and adds license information; record audit trail.

Typical workflow for electronic completion and routing

This describes a common digital workflow from intake to archival for clinical and administrative use.

Intake: Capture patient details and consent in the EHR or intake form.
Assessment: Clinician completes evaluation fields and attaches test orders.
Verification: Lab results return and are linked to the evaluation record.
Storage: Final signed record is archived with audit trail and access controls.

Common digital configuration options for online completion

Configure these settings to align the evaluation form with clinical systems and compliance needs.

Field	Configuration
Authentication Method	Email plus optional SMS code for signer verification
Template Management	Save standard evaluation templates with required fields
Lab Integration	Include LIMS ID field for automated result linking
Consent Capture	Present HIPAA disclosure and obtain electronic consent

Technical requirements for secure eCompletion and sharing

Ensure platform support for privacy, signatures, and integration with clinical systems before e-submission.

Encryption: TLS in transit; AES-256 at rest
Audit Trail: Timestamped logs and signer attribution
Integrations: EHR and cloud storage connectors

Choose a platform that supports HIPAA Business Associate Agreements, audit logs, and the integrations you need for clinical workflows.

Security and compliance checkpoints to include

HIPAA: BAA required for vendor handling PHI

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest

Audit Trail: Signed events with timestamps and IP

Access Controls: Role-based access and MFA where available

21 CFR Part 11: Required for FDA-regulated records when applicable

Retention Policy: Follow HIPAA and state record retention rules

Key risks and consequences of incorrect or incomplete evaluations

HIPAA Violation: Civil and criminal penalties for unauthorized PHI disclosure

Clinical Harm: Misdiagnosis or inappropriate treatment from missing data

Chain-of-Custody Errors: Lab result admissibility may be challenged

Insurance Denial: Reimbursement risk if documentation is insufficient

Legal Challenges: Evidence may be excluded without reliable audit trail

Regulatory Penalties: State reporting failures can trigger fines

Common mistakes to avoid

Incomplete patient identity fields that prevent matching results to the correct record and delay care decisions.
Missing specimen ID or chain-of-custody entries that render lab results unreliable for legal or employment use.
Failure to capture or store required HIPAA consent and disclosures for electronic delivery or sharing of records.
Using initials or unsigned notes in place of a full clinician signature and license information required for evidentiary use.

Anatomy of a professional Healthcare Substance Evaluation

A complete evaluation includes standardized sections that support clinical clarity, auditability, and regulatory compliance.

Patient Demographics

Full legal name, DOB, medical record number, and contact information to ensure correct identity and record linkage.

Clinical History

Relevant history including exposure context, symptom timeline, prescription and OTC use, prior substance-related events, and co-morbidities.

Substance Inventory

List substances evaluated with concentrations, formulations, and route of exposure when known, using precise names.

Test Results

Attach or transcribe laboratory and toxicology results with specimen ID, collection date/time, and lab accession number.

Interpretation

Clinician’s assessment of findings, differential diagnosis, and relevance to symptoms or workplace fitness.

Recommendations

Treatment steps, follow-up testing, work restrictions, referrals, and any required reporting or notification actions.

Time-sensitive milestones and record timelines

Observing these timing expectations helps maintain clinical utility and regulatory compliance.

Evaluation timing:

Document findings at the time of encounter to preserve contemporaneous clinical detail.

Specimen handling:

Send specimens to the lab per manufacturer and lab instructions, typically within 24–48 hours.

Result reporting:

Attach final lab reports to the evaluation once results are verified by the lab.

HIPAA retention:

Retain healthcare records for six years per 45 CFR §164.530(j).

Employer notification:

Provide occupational findings to authorized employer contacts consistent with consent and privacy rules.

Illustrative examples of use in clinical and occupational settings

Two concise scenarios show how an evaluation supports care, workplace decisions, or administrative review.

Community Clinic Evaluation

A primary care clinician documents acute exposure symptoms and orders toxicology.

Lab returns confirm a specific substance concentration.
The completed evaluation, with signed clinician interpretation and attached lab report, guided treatment, follow-up testing, and a safe discharge plan for the patient.

Occupational Health Review

An on-site occupational clinician evaluates potential workplace exposure and records job tasks.

Specimen sent under chain-of-custody procedures.
The evaluation supported a restricted-duty recommendation and a documented return-to-work plan while protecting patient privacy consistent with employer notification rules.

Comparing eSignature vendor pricing and core features for this use case

This table summarizes starting prices and selected feature availability to consider when choosing an eSignature platform for Healthcare Substance Evaluations.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no credit card required	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently asked questions and practical answers

Answers to common questions about legal validity, signatures, privacy, and correcting errors in an evaluation.

Need help? Contact support

Can this be signed electronically?
Yes. Electronic signatures are legally valid under the federal ESIGN Act (15 U.S.C. ch. 96) and UETA where adopted; ensure intent, consent, attribution, and retention are documented for enforceability.
Is eSubmission HIPAA-compliant?
It can be if the vendor signs a Business Associate Agreement and implements safeguards (access controls, encryption, audit trail). HIPAA requires administrative, physical, and technical protections for PHI.
What if a specimen was mislabeled?
Document the chain-of-custody discrepancy, notify the lab and treating clinician, and repeat collection if clinically required; chain-of-custody problems can invalidate results for employment or legal purposes.
Who is authorized to sign the evaluation?
The treating clinician or designated medical reviewer with appropriate credentials should sign; the signature must include name, credentials, license number, and date to be admissible and actionable.
How do I correct an error after signing?
Add a signed addendum noting the correction and reason; do not alter the original signed record. Maintain both original and addendum with an audit trail for transparency.
How long must the evaluation be kept?
Follow HIPAA baseline retention of six years from creation or last effective date (45 CFR §164.530(j)), and extend retention per any applicable state or program-specific requirement.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now